Literature DB >> 19454430

Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up.

L Licitra1, E Felip.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19454430     DOI： 10.1093/annonc/mdp149

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  19 in total

1.  STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN.

Authors:  Vassiliki Kotoula; Sofia Lambaki; Despina Televantou; Anna Kalogera-Fountzila; Angelos Nikolaou; Konstantinos Markou; Despina Misailidou; Konstantinos N Syrigos; George Fountzilas
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

2.  Cisplatin versus cetuximab given concomitantly with radiotherapy in non-resectable head and neck squamous cell carcinoma: an open question.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-25       Impact factor: 2.503

3.  Dynamic Contrast-Enhanced MRI Parameters as Biomarkers in Assessing Head and Neck Lesions After Chemoradiotherapy Using a Wide-Bore 3 Tesla Scanner.

Authors:  Gergely Lerant; Peter Sarkozy; Zoltan Takacsi-Nagy; Gabor Polony; Laszlo Tamas; Erika Toth; Andras Boer; Laszlo Javor; Maria Godeny
Journal:  Pathol Oncol Res       Date:  2015-04-30       Impact factor: 3.201

4.  Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab.

Authors:  Edgar Selzer; Susanne Liederer; Christiane Lemaire; Gerhard Kren; Dejan Radonjic; Gabriela Kornek; Thomas Knocke; Richard Pötter; Barbara Bachtiary
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

5.  Definitive radiochemotherapy or initial surgery for oropharyngeal cancer : To what extent can p16 expression be used in the decision process?

Authors:  Anouchka Modesto; Thibaut Galissier; Amélie Lusque; Jean-Pierre Delord; Emmanuelle Uro-Coste; Jérôme Sarini; Frédéric Mouchet; Raphaël Lopez; Anne Laprie; Pierre Graff; Sébastien Vergez; Michel Rives
Journal:  Strahlenther Onkol       Date:  2019-03-15       Impact factor: 3.621

6.  Success of endoscopic pharyngoesophageal dilation after head and neck cancer treatment.

Authors:  Claudia I Chapuy; Donald J Annino; Roy B Tishler; Robert I Haddad; Anna Snavely; Laura A Goguen
Journal:  Laryngoscope       Date:  2013-07-08       Impact factor: 3.325

7.  Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.

Authors:  P Bossi; E Orlandi; R Miceli; F Perrone; M Guzzo; L Mariani; R Granata; L Locati; C Fallai; B Cortelazzi; S Pilotti; G Scaramellini; A Gloghini; L Licitra
Journal:  Ann Oncol       Date:  2014-02-07       Impact factor: 32.976

8.  Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer: immunochemo and radiotherapy with erbitux) - a multicenter phase IV trial.

Authors:  G Habl; K Potthoff; M F Haefner; A Abdollahi; J C Hassel; E Boller; M Indorf; J Debus
Journal:  BMC Cancer       Date:  2013-07-15       Impact factor: 4.430

9.  Head and neck cancers: a clinico-pathological profile and management challenges in a resource-limited setting.

Authors:  Japhet M Gilyoma; Peter F Rambau; Nestory Masalu; Neema M Kayange; Phillipo L Chalya
Journal:  BMC Res Notes       Date:  2015-12-12

10.  The impact of sphingosine kinase-1 in head and neck cancer.

Authors:  Paulette M Tamashiro; Hideki Furuya; Yoshiko Shimizu; Kayoko Iino; Toshihiko Kawamori
Journal:  Biomolecules       Date:  2013-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.